BBOT · CIK 0001869105 · operating
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $806 million, BridgeBio Oncology Therapeutics, Inc. is a small-cap company. The stock currently trades at $10.08, up 0.50% today, with a 52-week range of $8.50–$14.87.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-11 | 0001213900-25-022387 | SEC ↗ |